✦ LIBER ✦

The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain

✍ Scribed by R.D. POCKETT; D. CASTELLANO; P. MCEWAN; A. OGLESBY; B.L. BARBER; K. CHUNG

Book ID: 108710815
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 236 KB
Volume: 19
Category: Article
ISSN: 0961-5423
DOI: 10.1111/j.1365-2354.2009.01135.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Skeletal-related events (SREs) in breast

✍ Mateya Trinkaus; Christine Simmons; Jeff Myers; George Dranatisaris; Mark Clemon 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 124 KB

Survival in breast cancer patients with

Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999–2007)

✍ Mellissa Yong; Annette Østergaard Jensen; Jacob Bonde Jacobsen; Mette Nørgaard; 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 232 KB

Serum C-telopeptide levels predict the i

Serum C-telopeptide levels predict the incidence of skeletal-related events in cancer patients with secondary bone metastases

✍ María Concepción López-Carrizosa; Pilar María Samper-Ots; Aurora Rodríguez Pérez 📂 Article 📅 2010 🏛 Springer Milan 🌐 Spanish ⚖ 139 KB

Decreases in pain at rest and movement-r

Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot study

✍ Carla Ripamonti; Elena Fagnoni; Tiziana Campa; Vincenzo Giardina; Cinzia Brunell 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 159 KB

A phase II trial evaluating the palliati

A phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy

✍ Mark Clemons; George Dranitsaris; Wei Ooi; David E. C. Cole 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 346 KB

Detection of the neural cell adhesion mo

Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small-cell lung cancer (SCLC) with “limited” or “extensive” disease, and bone-marrow infiltration

✍ J. A. Ledermann; F. Pasini; Y. Olabiran; G. Pelosi 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 416 KB

The neural cell adhesion molecule (NCAM) is a tumourrelated antigen found on the surface of small-cell lung cancer (SCLC). NCAM exists in several molecular forms, including a soluble isoform. We have measured serum levels of NCAM using an enzyme immunoassay with 2 anltibodies, NCC-LU-246 and NCC-LU-